Estrogen molecule

Chouinard S, Tessier M, Vemouillet G, et al. Inactivation of the pure antiestrogen fulvestrant and other synthetic estrogen molecules by UDP-glucuronosyltransferase 1A enzymes expressed in breast tissue. Mol Pharmacol 2006 69(3) 908-920. 

Vessieres A, Spera D, Top S, Misterkiewicz B, Heldt JM, Hillard EA, Huche M, Plamont MA, Napolitano E, Fiaschi R, Jaouen G (2006) The presence of a ferrocenyl unit on an estrogenic molecule is not always sufficient to generate in vitro cytotoxicity. ChemMed-Chem 1 1275-1281... 

The existence of secondary metabolites that may fortuitously bind to proteins in the human body may also be illustrated in the nutrition field. Some recent research has investigated plant estrogens, molecules that may have hormonal activity in humans, despite the fact that they have no similar role in the plant. Thus, chance interactions of external molecules with human proteins is a major topic of consideration in all of biological sciences. 

Here again, ferrocene alone is not toxic. In addition, it has been shown that derivatives of estradiol bearing a ferrocenyl substituent in position 17a, 32 and 33 have an estrogenic effect in vitro, and are devoid of any cytotoxic effect either on hormone-dependent or hormone-independent ceUs [71]. Simply delivering an estrogenic molecule bearing a ferrocenyl substituent payload into the interior of a target cell is not sufficient to obtain a cytotoxic effect. The production of this effect seems to be linked to a spedfic structure that allows the ferrocenyl - double bond - phenol pattern to come into play. 

The reduction of the 17-keto function to 17 8-hydroxy for Cw steroids is generally limited in the placental tissues. On the other hand, we will see later on (Section III, G) that the concentration of placental estradiol is greater tlian that of estrone, indicating that after aromatization there is a significant reduction of the 17-keto function in the estrogen molecule. 

We will now turn our attention to another example of the application of FT-IR, this time in the area of hormone-receptor site detection through the detection of organometallic labels [7]. When an estrogen molecule enters a cell from the blood stream it searches for a specific receptor protein and the resultant estrogen-receptor complex ultimately affects new protein... 

Steroids are synthetic products of cholesterol [57-88-5]. The chemical stmcture of a steroid hormone is determined by sequential enzymatic processing of the cholesterol molecule. Steroid products differ among steroid-secreting glands because of differences in enzyme processing, eg, the production of estrogen by the ovary requires enzymatic steps that do not occur in the adrenal cortex. 

As noted previously, triarylethylenes substituted by a basic group, such as clomiphene, exhibit estrogen antagonist activity. Formal cyclization of that molecule to a more steroid-like, rigid conformation enhances potency in this series. 

Although estrone and estradiol (26) have both been isolated from human urine, it has recently been shown that it is the latter that is the active compound that binds to the so-called estrogen receptor protein. Reduction of estrone with any of a large number of reducing agents (for example, any of the complex metal hydrides) leads cleanly to estradiol. This high degree of stereoselectivity to afford the product of attack at the alpha side of the molecule is characteristic of many reactions of steroids. 

A large number of molecules have provided experimental evidence of neuroprotection in in vitro and in vivo models of Parkinson s disease and many of these putative neuroprotective substances are now the objects of clinical trials. Recently, a team of experts has identified potential neuroprotective agents to be tested in pilot studies [4]. Twelve compounds have been considered for clinical trials caffeine, coenzyme Q 10, creatine, estrogen, GPI1485, GM-1 ganglioside, minocycline, nicotine, pramipexole, ropinirol, rasagiline, and selegiline (for individual discussion see [4]). 

A widely used 3-D QSAR method that makes use of PLS is comparative molecular field analysis (CoMFA), in which a probe atom is used to calculate the steric and electronic fields at numerous points in a 3D lattice within which the molecules have been aligned. Poso et al. [56] used the technique to model the binding of coumarins to cytochrome P450 2A5, with similar results to those obtained by Bravi and Wikel [55]. Shi et al. [57] used it to model the estrogen receptor binding of a large diverse set of compounds, and Cavalli et al. [58] used it to develop a pharmacophore for hERG potassium... 

Reaction of estrone (2) with an excess of the lithium reagent from 3-iodofuran gives intermediate diol 3. The stereochemical assignment follows from the well-known propensity of steroids for attack from the less-hindered backside (a) of the molecule. Acylation of 3 with acetic anhydride then affords the estrogen estrvfurate (4).1... 

Some steroid molecules (estrone, estradiol, and estriol) have phenolic hydroxyl in the ring A (Figure 29.12) and therefore, are able to react as free radical scavengers. In 1987, Japanese authors [264,265] showed that all these compounds inhibited iron adriamycin- or iron ADP-ascorbate-dependent phospholipid and liposomal lipid peroxidation. Later on, most attention was drawn to the study of antioxidative properties of estradiol-17(3 (estrogen E2) it has been proposed that E2 antioxidant activity may contribute to cardioprotection observed after estrogen therapy in postmenopausal women. The necessity for the phenolic hydroxyl has been shown by studying the effects of several estrogens on LDL oxidation. It was found [266]... 

---